Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$28.86 -0.79 (-2.66%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Other Operating Expenses (2016 - 2026)

Updated

Lakefront Biotherapeutics' Other Operating Expenses was $1.76 million in the quarter ended Jun 30, 2026, down 81.2% from $9.4 million a year earlier but up 39.3% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Other Operating Expenses (2016 - 2026) Analysis & Trends

On a trailing twelve-month basis, Lakefront Biotherapeutics' Other Operating Expenses was $62.25 billion through Jun 30, 2026; for the year ended Dec 31, 2025, it came in at $60.44 billion.

  • Other Operating Expenses shows a five-year compound annual growth rate of 299.2% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Other Operating Expenses was $44.13 million in the year ended Dec 31, 2024 (-13.2%), $50.86 million in the year ended Dec 31, 2023 (+33.6%), $38.08 million in the year ended Dec 31, 2022 (-30.2%) and $54.52 million in the year ended Dec 31, 2021 (-8.5%).
  • Quarterly Other Operating Expenses has moved between -$32.71 million (the quarter ended Sep 30, 2024) and $62.24 billion (the quarter ended Dec 31, 2025) over five years.
  • Compared with a year earlier, Other Operating Expenses was higher in 1 of the last five quarters, with growth averaging 10.7%.
  • The best year-over-year quarter for Other Operating Expenses over five years was the quarter ended Dec 31, 2024 (growth of 329.4%); the worst was the quarter ended Mar 31, 2026 (a decline of 81.7%).
  • Per Business Quant data, LKFT's Other Operating Expenses in the three quarters before the quarter ended Jun 30, 2026 was $1.27 million (quarter ended Mar 31, 2026), $62.24 billion (quarter ended Dec 31, 2025) and $7.57 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lakefront Biotherapeutics 1.95 Bn 1.95 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.76 Mn
Mar 31, 2026 1.27 Mn
Dec 31, 2025 62.24 Bn
Sep 30, 2025 7.57 Mn
Jun 30, 2025 9.40 Mn
Mar 31, 2025 6.94 Mn
Dec 31, 2024 60.06 Mn
Sep 30, 2024 -32.71 Mn
Jun 30, 2024 48.69 Mn
Mar 31, 2024 10.20 Mn
Dec 31, 2023 13.99 Mn
Sep 30, 2023 13.77 Mn
Jun 30, 2023 14.66 Mn
Mar 31, 2023 7.34 Mn
Dec 31, 2022 6.79 Mn
Sep 30, 2022 11.97 Mn
Jun 30, 2022 10.59 Mn
Mar 31, 2022 8.62 Mn
Dec 31, 2021 11.18 Mn
Sep 30, 2021 42.81 Mn
API Access

Lakefront Biotherapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=LKFT&period=max&api_key=YOUR_API_KEY